INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 129 filers reported holding INSMED INC in Q4 2018. The put-call ratio across all filers is 5.35 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $212,000 | -76.9% | 9,032 | -73.2% | 0.00% | -66.7% |
| Q4 2021 | $919,000 | +4.4% | 33,732 | +5.5% | 0.00% | 0.0% |
| Q3 2021 | $880,000 | +11.4% | 31,959 | +15.2% | 0.00% | 0.0% |
| Q2 2021 | $790,000 | -77.8% | 27,745 | -73.5% | 0.00% | -81.2% |
| Q1 2021 | $3,562,000 | -39.4% | 104,564 | -40.8% | 0.02% | -38.5% |
| Q4 2020 | $5,879,000 | -25.6% | 176,601 | -28.2% | 0.03% | -16.1% |
| Q3 2020 | $7,907,000 | +682.9% | 246,006 | +570.7% | 0.03% | +520.0% |
| Q2 2020 | $1,010,000 | -88.9% | 36,681 | -90.4% | 0.01% | -83.3% |
| Q4 2019 | $9,116,000 | +35.0% | 381,763 | -0.3% | 0.03% | +20.0% |
| Q3 2019 | $6,753,000 | -42.2% | 382,822 | -16.2% | 0.02% | -40.5% |
| Q2 2019 | $11,692,000 | +14.3% | 456,736 | +29.8% | 0.04% | +7.7% |
| Q1 2019 | $10,229,000 | +45.3% | 351,907 | -34.4% | 0.04% | +25.8% |
| Q4 2018 | $7,042,000 | +467.0% | 536,761 | +922.7% | 0.03% | +520.0% |
| Q2 2018 | $1,242,000 | – | 52,485 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,889,491 | $148,709,648 | 14.07% |
| Deep Track Capital, LP | 6,000,000 | $151,500,000 | 5.85% |
| Octagon Capital Advisors LP | 1,284,000 | $32,421,000 | 4.98% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,446,334 | $87,019,934 | 4.70% |
| MPM BioImpact LLC | 527,458 | $13,318,315 | 3.56% |
| Novo Holdings A/S | 1,339,304 | $33,817,426 | 2.50% |
| Bleichroeder LP | 325,000 | $8,206,250 | 2.02% |
| GREAT POINT PARTNERS LLC | 394,872 | $9,970,518 | 1.82% |
| Endurant Capital Management LP | 79,471 | $2,006,643 | 1.80% |
| SECTORAL ASSET MANAGEMENT INC | 347,392 | $8,771,648 | 1.71% |